サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790458

臨床検査機器と補助ソリューションの市場規模、シェア、動向分析レポート：タイプ別、フェーズ別、地域別、セグメント予測、2025年～2033年

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.78円
臨床検査機器と補助ソリューションの市場規模、シェア、動向分析レポート：タイプ別、フェーズ別、地域別、セグメント予測、2025年～2033年
出版日: 2025年07月23日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査機器と補助ソリューション市場概要

臨床検査機器と補助ソリューションの世界市場規模は、2024年に32億1,000万米ドルと評価され、2033年には68億8,000万米ドルに達すると予測され、2025～2033年のCAGRは8.92%で成長します。市場成長の背景には、臨床検査の複雑化とグローバリゼーションがあり、高度に専門化されたプロトコル固有の機器やロジスティクス支援が求められています。

分散型とハイブリッド型臨床検査モデルの急速な採用により、遠隔モニタリング機器、ウェアラブルセンサ、家庭用診断キットが必要となり、補助サービスの範囲が大幅に拡大しています。臨床検査モデルの変革、特に分散型検査やハイブリッド検査の増加により、遠隔地、サイトレス、在宅での研究環境を促進する特殊な機器やサポートサービスへの需要が大幅に高まっています。中央集中型の治験施設に大きく依存していた従来型モデルは、より患者に焦点を当てたアプローチに取って代わられつつあり、遠隔モニタリング機器、モバイルヘルスキット、ウェアラブル、生物学的サンプルの宅配便対応ロジスティクスなどが必要とされています。例えば、米国FDAは2023年ガイダンス案を通じて分散型臨床検査（DCT）を推進し、スポンサーに対し、患者アクセスとデータの質を高めるためにデジタルヘルス技術やリモートケアツールを採用するよう促しています。このような開発により、CROやスポンサーは、信頼性の高い温度感受性包装、検証済みの在宅用医療機器、異なる地域をまたがる機器出荷を監督するリアルタイム追跡システムを取得するようになっています。このシフトにより、臨床検査機器サプライヤーの役割は、受動的なベンダーから、規制遵守、適切なキャリブレーション、検査プロトコールに沿った納品スケジュールの確保を担う能動的で統合的なサービスパートナーへと変化しています。

さらに、政府や非営利の資金提供機関は、初期段階の研究、トランスレーショナル・メディシン、医師主導治験を支援する傾向を強めており、これらすべてが治験補助用品へのタイムリーなアクセスに依存しています。NIHのAll of Us Research Programや欧州の連合のHorizon Europeの枠組みのようなイニシアチブは、患者コホートの多様性と精密診断の境界を広げつつあり、適応性と柔軟性のある機器供給戦略を必要としています。例えば、Horizon Europeでは、2027年までの科学とイノベーションに向けて約1,114億9,000万米ドル（950億ユーロ）が割り当てられ、個別化医療、ウェアラブル・モニタリング、遠隔医療統合臨床検査に焦点を当てた複数のプロジェクトが実施されています。このような構想は、治験実施施設対応のキット、クラウドに接続されたモニタリング機器、試薬や生物製剤のデジタル追跡可能な出荷に対する需要を生み出しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床検査機器と補助ソリューション市場：変数、動向、範囲

  • 市場系統の展望
  • 臨床検査機器と補助ソリューション市場力学
  • 技術
  • 価格モデル分析
  • 臨床検査機器と補助ソリューション市場：分析ツール

第4章 臨床検査機器と補助ソリューション市場：タイプ別、推定・動向分析

  • セグメントダッシュボード
  • 世界の臨床検査機器と補助ソリューション市場のタイプ変動分析
  • 世界の臨床検査機器と補助ソリューション市場規模と動向分析（タイプ別、2021～2033年）
  • ソーシング
    • 調達
    • レンタル
  • 供給/物流
    • 輸送
    • 包装
    • その他
  • サービス
    • キャリブレーション
    • 機器のメンテナンス
    • その他
  • その他

第5章 臨床検査機器と補助ソリューション市場：相別、推定・動向分析

  • セグメントダッシュボード
  • 世界の臨床検査機器と補助ソリューション市場のフェーズ変動分析
  • 世界の臨床検査機器と補助ソリューション市場規模と動向分析（相別、2021～2033年）
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第6章 臨床検査機器と補助ソリューション市場：タイプ、フェーズによる地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2021～2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業分類
    • マーケットリーダー
    • 新興参入企業
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere
    • Quipment SAS
    • IRM
    • Marken
    • Myonex
    • Yourway
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 16 France clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 31 China clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 35 India clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 Clinical trial equipment & ancillary solutions market, by type segment: Market share, 2025 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 Clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Heat map analysis
目次
Product Code: GVR-4-68039-533-5

Clinical Trial Equipment & Ancillary Solutions Market Summary

The global clinical trial equipment & ancillary solutions market size was valued at USD 3.21 billion in 2024 and is projected to reach USD 6.88 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The growth of the market is due to the increasing complexity and globalization of clinical trials, which demand highly specialized, protocol-specific equipment and logistics support.

The rapid adoption of decentralized and hybrid trial models requires remote monitoring devices, wearable sensors, and home-use diagnostic kits, significantly expanding the scope of ancillary services. The transformation of clinical trial models, especially the increase of decentralized and hybrid trials, has significantly raised the demand for specialized equipment and support services that facilitate remote, site-less, and home-based research settings. The traditional model, which relied heavily on centralized trial sites, is being replaced by more patient-focused approaches, requiring remote monitoring devices, mobile health kits, wearables, and courier-enabled logistics for biological samples. For example, the U.S. FDA has promoted decentralized clinical trials (DCTs) through its 2023 draft guidance, urging sponsors to adopt digital health technologies and remote care tools to enhance patient access and data quality. These developments are leading CROs and sponsors to acquire reliable, temperature-sensitive packaging, validated medical devices for home use, and real-time tracking systems to oversee equipment shipments across different regions. This shift has transformed the role of clinical trial equipment suppliers from passive vendors into active, integrated service partners responsible for ensuring regulatory compliance, proper calibration, and delivery schedules aligned with study protocols.

Additionally, government and non-profit funding organizations are increasingly supporting early-stage research, translational medicine, and investigator-initiated trials, all of which depend on timely access to ancillary trial supplies. Initiatives like the NIH's All of Us Research Program and the European Union's Horizon Europe framework are expanding the boundaries of patient cohort diversity and precision diagnostics, which require adaptive and flexible equipment supply strategies. For example, Horizon Europe allocates nearly USD 111.49 billion (€95 billion) toward science and innovation through 2027, with multiple projects focused on personalized medicine, wearable monitoring, and telehealth-integrated clinical trials. These initiatives generate demand for site-ready kits, cloud-connected monitoring devices, and digitally traceable shipping for reagents and biologics.

Global Clinical Trials Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical trial equipment & ancillary solutions market report based on type, phase and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis by Type, Phase

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Ancillare, LP
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Imperial CRS, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Service benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Woodley Equipment Company Ltd.
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Service benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Thermo Fisher Scientific, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Service benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Parexel International (MA) Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Service benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Emsere
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Service benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quipment SAS
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Service benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. IRM
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Service benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Marken
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Service benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Myonex
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Service benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Yourway
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Service benchmarking
      • 7.3.11.4. Strategic initiatives